Carrier Biomed (亿航生物)

Carrier Biomed (亿航生物)is currently with an exosome isolation platform with independent intellectual property rights and multiple pipelines based on thousands of large-scale multi-center clinical studies including early blood diagnosis of neurodegenerative diseases, early diagnosis and dynamic monitoring of tumor; the company meanwhile is with an exosome production workshop with the international level.